ADM, Asahi Group partner to distribute lactic acid-based innovative post biotic

USA – ADM, a global leader in innovative human and animal nutrition, has partnered Asahi Group Foods Corporation, to exclusively market and distribute Asahi Group’s proprietary lactic acid-based postbiotic, Lactobacillus gasseri CP2305.

The lactic acid-based postbiotic was backed by eight human clinical trials and is capable of targeting stress, mood, and sleep support.

The postbiotic’s introduction to ADM’s portfolio comes as products targeting mood/relaxation support grew at a double-digit CAGR of 13% from 2018-2023, with a category growth of nearly 34%.

Mark Lotsch, ADM’s President of Global Health and Wellness, stated, “Stress, mood, and sleep are among the fastest-growing wellness segments. As the cornerstones of physical and emotional health, they are also some of the most disruptive factors to everyday life and overall well-being if not properly supported.

“Our agreement with pioneering Asahi Group to bring science-backed L. gasseri CP2305 postbiotic into our robust health and wellness solutions library is a critical step in advancing new product development to support consumers’ quality of life worldwide.”

Lotsch mentioned that the inclusion of L. gasseri CP2305 enhances their postbiotics offerings, strengthening their commitment to providing robust ingredients with significant health and wellness outcomes.

These scientifically validated ingredients are expected to play a key role in advancing the next generation of functional foods, supporting the shifting wellness objectives of consumers worldwide.

Through many years of research on Calpis-derived lactic acid bacteria, Asahi Group discovered L. gasseri CP2305.

Based on the Group, the agreement will strengthen its lactic acid bacteria materials business and meet increasing demand for diverse functional food products through ADM’s extensive global network and R&D centers.

Kazuhiro Hayashi, Corporate Officer and senior General Manager of Asahi Group Foods, added, “Asahi is committed to solving global food and health challenges, especially those contributing to mental and physical well-being for consumers.

“We’re excited to enter a supply agreement with ADM for Lactobacillus gasseri CP2305, leveraging their expertise in microbiology and global scale to effectively expand the reach of this innovative solution.”

The group stated that L. gasseri CP2305 offered a new avenue for innovation in health and wellness, addressing the rising need for stress management and sleep quality solutions.

It is a postbiotic with clinically documented evidence supporting the physiological functions that the gut-brain axis can influence.

As a postbiotic, L. gasseri CP2305 can withstand numerous formulation environments, including tough conditions like high heat or high water content commonly associated with functional foods and on-trend dosage formats such as gummies.

Subscribe to our email newsletters that provide busy executives like you with the latest news insights and trends from Africa and the World. SUBSCRIBE HERE